Acer Medical Inc. 6857.TWO
6857.TWO
Acer Medical Inc. 3054.TW
LIWANLI Innovation Co., Ltd. 4195.TWO
Genomics BioSci & Tech. Co.,Ltd. 4111.TWO
Chi Sheng Pharma & Biotech Co., Ltd 4153.TWO
DIVA Laboratories, Ltd. 6130.TWO
Shangya Technology Co., Ltd. 1762.TW
Chunghwa Chemical Synthesis & Biotech Co., Ltd. 4724.TWO
Meribank Biotech Co., Ltd 4173.TWO
Arich Enterprise Co., Ltd. 4127.TWO
Tien Liang BioTech Co., Ltd.
Acer Medical Inc. 3054.TW
LIWANLI Innovation Co., Ltd. 4195.TWO
Genomics BioSci & Tech. Co.,Ltd. 4111.TWO
Chi Sheng Pharma & Biotech Co., Ltd 4153.TWO
DIVA Laboratories, Ltd. 6130.TWO
Shangya Technology Co., Ltd. 1762.TW
Chunghwa Chemical Synthesis & Biotech Co., Ltd. 4724.TWO
Meribank Biotech Co., Ltd 4173.TWO
Arich Enterprise Co., Ltd. 4127.TWO
Tien Liang BioTech Co., Ltd.
Performance
| Periode | 6857.TWO | 3054.TW | 4195.TWO | 4111.TWO | 4153.TWO | 6130.TWO | 1762.TW | 4724.TWO | 4173.TWO | 4127.TWO |
|---|---|---|---|---|---|---|---|---|---|---|
| 6M | 1.69 % | -3.44 % | 46.67 % | 1.48 % | -11.49 % | 25.00 % | -10.86 % | 16.30 % | 8.28 % | -12.53 % |
| YTD | -15.14 % | -3.83 % | 37.50 % | 13.05 % | -1.19 % | 76.53 % | -23.86 % | -33.63 % | 6.08 % | -23.59 % |
| 1Y | -21.75 % | 11.45 % | 52.60 % | 20.60 % | -13.54 % | 58.44 % | -39.39 % | -38.37 % | 14.32 % | -14.30 % |
| 3Y | 66.21 % | 21.07 % | 44.98 % | 37.05 % | 47.63 % | 34.68 % | -49.61 % | -40.16 % | 39.76 % | 147.08 % |
| 5Y | 0.53 % | 4.84 % | 61.37 % | 33.29 % | 26.18 % | 79.03 % | -58.57 % | -40.16 % | -1.05 % | 164.58 % |
| 10Y | 0.53 % | -1.78 % | 55.84 % | 40.10 % | -55.63 % | 60.39 % | -22.37 % | -40.16 % | -7.14 % | 33.97 % |
| From the beginning | 0.53 % | -89.35 % | -12.38 % | 136.66 % | 177.49 % | -1.07 % | -59.03 % | -40.16 % | -0.21 % | 97.70 % |